Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Prepaid Assets came in at $12.1 million in Q2 2026, up 79.36% YoY from $6.8 million in Q2 2025, and down 8.35% on a QoQ basis from $13.2 million in Q1 2026.
Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Prepaid Assets data on file, last reported at $12.1 million in Q2 2026.
- Quarterly Prepaid Assets rose 79.36% year-over-year to $12.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.1 million (up 79.36% YoY) and the FY2025 annual result came in at $8.4 million, down 12.04% from the prior year.
- Prepaid Assets retreated to $12.1 million in Q2 2026, from $13.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q1 2026 to a low of $6.6 million in Q2 2022.
- A 5-year average of $9.1 million and a median of $8.7 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2025 — Prepaid Assets tumbled 44.36% — and 2026, when it soared 79.36%.
- Tracing WVE's Prepaid Assets over 5 years: stood at $7.9 million in 2022, then grew by 24.96% to $9.9 million in 2023, then slipped by 3.71% to $9.5 million in 2024, then fell by 12.04% to $8.4 million in 2025, then soared by 44.38% to $12.1 million in 2026.
- The last three Prepaid Assets figures came in at $12.1 million (Q2 2026), $13.2 million (Q1 2026), and $8.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.12 Mn |
| Mar 31, 2026 | 13.23 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 6.65 Mn |
| Jun 30, 2025 | 6.76 Mn |
| Mar 31, 2025 | 8.06 Mn |
| Dec 31, 2024 | 9.54 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 4.68 Mn |
| Mar 31, 2024 | 11.14 Mn |
| Dec 31, 2023 | 9.91 Mn |
| Sep 30, 2023 | 7.51 Mn |
| Jun 30, 2023 | 9.01 Mn |
| Mar 31, 2023 | 2.80 Mn |
| Dec 31, 2022 | 2.11 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 5.40 Mn |
| Mar 31, 2022 | 5.73 Mn |
| Dec 31, 2021 | 6.58 Mn |
| Sep 30, 2021 | 7.63 Mn |